This article, written by Sidhesh Phaldessai, provides an overview of geriatric psychopharmacology, including the epidemiology of mental health disorders in the older population, the physiological changes that occur with ageing and their impact on pharmacokinetics and pharmacodynamics, and the use of psychotropic medications in older adults
Medicinal cannabis firms in holding pattern on grassy green future
+Business
In print
Medicinal cannabis firms in holding pattern on grassy green future
Friday 12 April 2019, 02:49 PM
CannaSouth co-founders Mark Lucas and Nic Foreman in the lab
The prospect of medicinal cannabis products being sold on pharmacy shelves may become a reality as early as next year, following last year’s passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act. Several companies looking to capitalise on the law change have already formed, but they are unable to make their products until the Government creates a regulatory framework for their budding industry. Jonathan Chilton-Towle finds out what they are up to while they wait for the law to catch up with their aspirations
When I think of a cannabis business, my first thought is a clandestine basement containing rows of plants bathing in the fluorescent glow of LED light, Manu Caddie, Hikurangi Cannabis Company managing director Manu Caddie believes developing an export market is key to a sustainable medical cannabis industry